Substituted 6-aminopurines for targeting HSP90
US-10112947-B2 · Oct 30, 2018 · US
US11247994B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11247994-B2 |
| Application number | US-202117149747-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 15, 2021 |
| Priority date | Aug 30, 2018 |
| Publication date | Feb 15, 2022 |
| Grant date | Feb 15, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a 6-dithio-substituted-2′-deoxyguanosine compound and a preparation method thereof and use thereof in anti-tumor drugs. According to the present invention, a series of brand-new thioredoxin-1 (Trx-1) inhibitors are designed and synthesized by using 2′-deoxyguanosine as a structure mother nucleus. The compound according to the present invention is a structure of formula I, and Trx-1 activity inhibition testing is performed on the type of compounds, showing apparent inhibitory activity. It is indicated from in vitro and vivo researches that these compounds show significant anti-tumor effects on multiple types of tumors, can be applied to drugs for tumors related to human body cell proliferation, and provide a new path for the research of anticancer drugs.
Opening claim text (preview).
What is claimed is: 1. A method of treating colon cancer, comprising administering to a subject in need thereof a composition comprising a 6-dithio-substituted-2′-deoxyguanosine compound of formula I: wherein R is C1-8 alkyl, C1-8 fluoroalkyl, C1-8 chloroalkyl, C1-8 hydroxyalkyl, C1-8 ketoalkyl, —(C1-4 alkyl) R1, —(C1-4 alkyl) NH 2 , —(C1-4 alkyl) NH (C1-4 alkyl), phenyl selectively substituted by R2, a 5-membered aromatic ring selectively substituted with R2, C3-6 cycloalkyl selectively substituted with R2, or a 5 to 6-membered heteroaromatic ring containing at least one nitrogen and selectively substituted with R2; R1 is phenyl, phenyl selectively substituted with —F, —Cl, —OH, —NH 2 , —C1-4 alkyl, —OCH 3 , —CONH 2 or —CONHCH 3 , or a 5 to 6-membered heteroaromatic ring containing at least one nitrogen atom and selectively substituted with R2; and R2 is C1-4 alkyl, —CN, —OH, —OMe, —NH 2 , —NHMe, —N(CH 3 ) 2 , —F, —CF 3 , —CO(C1-4 alkyl), —COCH 2 CH 2 OH, or —CONHCH 3 . 2. The method according to claim 1 , wherein the 6-dithio-substituted-2′-deoxyguanosine compound is a compound having a structure selected from the group consisting of:
one nitrogen and one sulfur atom · CPC title
Processes for the preparation of sugar derivatives · CPC title
specific for leukemia · CPC title
with 2-deoxyribosyl as the saccharide radical · CPC title
Antineoplastic agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.